[Vasoconstrictive action of urotensin II].
Ikeda
Keiichi
K
Department of Pharmacology, Jikei University School of Medicine.
Tojo
Katsuyoshi
K
D000818:Animals; D048049:Extracellular Signal-Regulated MAP Kinases / Q000502:physiology; D043802:GTP-Binding Protein alpha Subunits, Gq-G11 / Q000502:physiology; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins; D020928:Mitogen-Activated Protein Kinases / Q000502:physiology; D011493:Protein Kinase C / Q000502:physiology; D017346:Protein Serine-Threonine Kinases / Q000502:physiology; D011505:Protein-Tyrosine Kinases / Q000502:physiology; D043562:Receptors, G-Protein-Coupled / Q000502:physiology; D015398:Signal Transduction / Q000235:genetics; D010738:Type C Phospholipases / Q000502:physiology; D014579:Urotensins / Q000494:pharmacology / Q000502:physiology*; D014661:Vasoconstriction / Q000187:drug effects; D014664:Vasodilation; D054460:rho-Associated Kinases
D047908:Intracellular Signaling Peptides and Proteins; D043562:Receptors, G-Protein-Coupled; C121697:UTS2R protein, human; D014579:Urotensins; C473142:Uts2r protein, rat; C029677:urotensin II; D011505:Protein-Tyrosine Kinases; D017346:Protein Serine-Threonine Kinases; D054460:rho-Associated Kinases; D011493:Protein Kinase C; D048049:Extracellular Signal-Regulated MAP Kinases; D020928:Mitogen-Activated Protein Kinases; D010738:Type C Phospholipases; D043802:GTP-Binding Protein alpha Subunits, Gq-G11